Associate Director, US Access Strategy - Oncology/Hematology Above Brand at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, HealthcareIndustries

Requirements

Must possess a Bachelor’s degree and an advanced degree is strongly preferred
3-5 years in the pharmaceutical industry or related consulting, and several years of market access experience (inferred from context)

Responsibilities

Lead the design and execution of payer and organized-customer strategies for the Oncology/Hematology portfolio; translate strategy into clear objectives, roadmaps, and pull-through plans across brands
Develop high-quality access resources (e.g., value messaging, objection handling, pull-through tools) and own the Med/Legal/Reg review process to ensure compliant, timely approval and deployment
Advance innovation in access strategy—pilot and scale the use of AI and advanced analytics to improve targeting, account planning, and content effectiveness; document learnings and share best practices
Act as the primary point of contact for the Access Field and brand teams; proactively solicit field insights and ensure they are reflected in strategy, tactics, and resource updates
Build strong internal partnerships with Commercial Brand teams, Medical, Business Insights & Technology, Patient Support, Trade, HEOR, Pricing, and Policy/Advocacy to ensure access strategies align to brand objectives and OneBMS priorities
Co-lead with Sales & Access Learning and Strategy & Operations to develop POA and launch-readiness content, training, and meeting materials
Maintain an external perspective by cultivating relationships with field leaders and key industry stakeholders to identify emerging trends, risks, and opportunities that inform strategy
Own the market-access component of OneBMS brand planning; ensure access strategies are embedded in annual/quarterly plans and that field tools and resources align to the plan
Continuously analyze the competitive landscape; anticipate and pre-empt competitor actions with differentiated value stories and tactical counter-measures across Market Access channels
Drive alignment on access strategy and key account plans in partnership with ONC NAEs, GPO/HCP Directors, and Payer Directors; support regional plan execution and pull-through
Establish clear KPIs and reporting with BI&T to track coverage quality, wins/losses, field utilization, and ROI; communicate progress and recommendations to leadership
Model compliance and ethical engagement in all activities; ensure all materials and tactics meet promotional regulatory requirements

Skills

Payer Strategy

Access Strategy

HEOR

Reimbursement

Value Messaging

Med/Legal/Reg Review

Oncology

Hematology

Pricing Strategy

Patient Access

Commercial Strategy

Portfolio Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free